Sign inGet started

RUSCHE JAMES R

Insider CIK 1241031 · RGEN Senior Vice President

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RGEN REPLIGEN CORP F Tax w/h2016-02-292016-03-011,419$26.05 $37.0K100,516SEC↗
RGEN REPLIGEN CORP A Award deriv2016-02-262016-03-019,895— $09,895SEC↗
RGEN REPLIGEN CORP A Award2016-02-262016-03-015,086— $0101,935SEC↗
RGEN REPLIGEN CORP S Sale2015-05-152015-05-1915,000$41.32 $619.8K96,849SEC↗
RGEN REPLIGEN CORP S Sale2015-03-192015-03-2514,650$33.30 $487.8K111,849SEC↗
RGEN REPLIGEN CORP A Award deriv2015-02-262015-03-0210,067— $010,067SEC↗
RGEN REPLIGEN CORP A Award2015-02-262015-03-025,229— $0126,499SEC↗
RGEN REPLIGEN CORP S Sale2014-06-092014-06-1030,000$20.19 $605.7K121,270SEC↗
RGEN REPLIGEN CORP M Exercise deriv2014-04-152014-04-1525,000— $00SEC↗
RGEN REPLIGEN CORP M Exercise deriv2014-04-152014-06-1125,000— $00SEC↗
RGEN REPLIGEN CORP P Buy2014-04-152014-04-1525,000$3.05 $76.3K151,270SEC↗
RGEN REPLIGEN CORP M Exercise2014-04-152014-06-1125,000$3.05 $76.3K151,270SEC↗
RGEN REPLIGEN CORP A Award deriv2014-02-272014-03-0312,727— $012,727SEC↗
RGEN REPLIGEN CORP A Award2014-02-272014-03-036,644— $0143,914SEC↗
RGEN REPLIGEN CORP S Sale2013-08-082013-08-0930,000$10.01 $300.3K137,270SEC↗
RGEN REPLIGEN CORP M Exercise deriv2013-08-072013-08-0950,000— $090,000SEC↗
RGEN REPLIGEN CORP M Exercise2013-08-072013-08-0950,000$5.87 $293.5K197,128SEC↗
RGEN REPLIGEN CORP F Tax w/h2013-08-072013-08-0929,858$9.83 $293.5K167,270SEC↗
RGEN REPLIGEN CORP M Exercise deriv2013-03-262013-03-2725,000— $0140,000SEC↗
RGEN REPLIGEN CORP M Exercise2013-03-262013-03-2725,000$5.51 $137.8K167,121SEC↗
RGEN REPLIGEN CORP F Tax w/h2013-03-262013-03-2719,993$6.89 $137.8K147,128SEC↗
RGEN REPLIGEN CORP A Award deriv2013-02-282013-03-1240,000— $0165,000SEC↗
RGEN REPLIGEN CORP S Sale2012-09-272012-10-021,133$6.09 $6.9K154,121SEC↗
RGEN REPLIGEN CORP S Sale2012-09-272012-10-02100$5.92 $592155,830SEC↗
RGEN REPLIGEN CORP S Sale2012-09-272012-10-021,138$5.91 $6.7K155,930SEC↗
RGEN REPLIGEN CORP S Sale2012-09-272012-10-022,053$5.90 $12.1K157,068SEC↗
RGEN REPLIGEN CORP S Sale2012-09-272012-10-02100$6.00 $600155,254SEC↗
RGEN REPLIGEN CORP S Sale2012-09-272012-10-02476$5.93 $2.8K155,354SEC↗
RGEN REPLIGEN CORP M Exercise deriv2012-03-272012-03-2825,000— $0125,000SEC↗
RGEN REPLIGEN CORP M Exercise2012-03-272012-03-2825,000$1.83 $45.8K167,641SEC↗
RGEN REPLIGEN CORP F Tax w/h2012-03-272012-03-288,520$5.37 $45.8K159,121SEC↗
RGEN REPLIGEN CORP M Exercise deriv2012-03-222012-03-2625,000— $0150,000SEC↗
RGEN REPLIGEN CORP F Tax w/h2012-03-222012-03-2616,233$4.99 $81.0K142,641SEC↗
RGEN REPLIGEN CORP M Exercise2012-03-222012-03-2625,000$3.24 $81.0K158,874SEC↗